Home » Stocks » Accuray

Accuray Incorporated (ARAY)

Stock Price: $2.59 USD 0.00 (0.00%)
Updated Aug 6, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 234.44M
Revenue (ttm) 405.37M
Net Income (ttm) 2.58M
Shares Out 90.52M
EPS (ttm) 0.02
PE Ratio 129.50
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $2.59
Previous Close $2.59
Change ($) 0.00
Change (%) 0.00%
Day's Open 2.60
Day's Range 2.53 - 2.62
Day's Volume 291,648
52-Week Range 1.33 - 4.68

More Stats

Market Cap 234.44M
Enterprise Value 366.14M
Earnings Date (est) Aug 13, 2020
Ex-Dividend Date n/a
Shares Outstanding 90.52M
Float 82.62M
EPS (basic) 0.02
EPS (diluted) 0.02
FCF / Share -0.17
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.77%
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.17M
Short Ratio 4.45
Short % of Float 3.42%
Beta 2.03
PE Ratio 129.50
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.58
PB Ratio 3.37
Revenue 405.37M
Operating Income 10.57M
Net Income 2.58M
Free Cash Flow -15.21M
Net Cash -131.71M
Net Cash / Share -1.46
Gross Margin 40.49%
Operating Margin 2.61%
Profit Margin 0.60%
FCF Margin -3.75%
ROA 1.68%
ROE 4.80%
ROIC 1.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 1

Analyst Consensus: Buy

Price Target

$7.00*
(170.27% upside)
Low
4.00
Current: $2.59
High
10.00
Target: 7.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue419405383399380369316409222222
Revenue Growth3.43%5.6%-3.86%5%2.81%16.91%-22.79%84.1%0.3%-
Gross Profit16316214115914514397.64137107104
Operating Income0.58-3.80-9.82-4.87-19.17-18.14-92.86-56.23-27.832.84
Net Income-16.43-23.90-29.58-25.50-40.21-35.45-103-72.04-26.682.84
Shares Outstanding87.4784.8982.5080.5178.2875.8073.2870.8960.0957.56
Earnings Per Share-0.19-0.28-0.36-0.32-0.51-0.47-1.41-1.02-0.440.05
Operating Cash Flow-29.6418.33-0.3830.93-14.410.35-66.18-38.2812.40-5.07
Capital Expenditures-4.31-6.28-5.03-8.07-10.45-11.93-15.13-10.77-4.02-5.13
Free Cash Flow-33.9512.06-5.4122.86-24.85-11.59-81.30-49.058.38-10.20
Cash & Equivalents88.1893.5310916914817317714599.08145
Total Debt16013116521020019619979.47--
Net Cash / Debt-71.67-37.54-55.43-41.04-52.06-22.22-21.6465.6099.08145
Assets438379406469467495476473456263
Liabilities38833036040939139736926921593.11
Book Value49.8748.6346.5359.6675.7898.55107196230170
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Accuray Incorporated
Country United States
Employees 947
CEO Joshua H. Levine

Stock Information

Ticker Symbol ARAY
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: ARAY
IPO Date February 8, 2007

Description

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.